The Hematologist

The Hematologist
  • 0,0 (0)
  • НАУКА
  • РАЗ В ДВА МЕСЯЦА

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

  1. -1 ДН.

    Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

    In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.

    22 мин.

  2. 9 МАР.

    VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia

    In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community.

    22 мин.

  3. 5 ФЕВР.

    Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society

    In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.

    23 мин.

  4. 22.10.2025

    An Homage to the Treg Graft in Allogeneic Transplantation

    In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD, professor of medicine at Stanford University and president-elect of ASH. They discuss recent developments in reducing graft versus host disease in allogenic stem cell transplant.

    23 мин.

  5. 11.09.2025

    Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

    In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.

    20 мин.

  6. 17.08.2025

    GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

    In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Autolus.

    21 мин.

  7. 28.07.2025

    More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

    In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.

    23 мин.

  8. 23.06.2025

    Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

    In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided by Autolus.

    22 мин.
См. все (163)

Об этом подкасте

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

Информация

  • Автор
    The Hematologist
  • Годы выхода
    2015 - 2026
  • Выпуски
    163
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © 2026 The Hematologist
  • Сайт подкаста
    The Hematologist

Вам может также понравиться